Best of the Blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In October, Windhover's editorial staff posted 25 articles to the site, covering biopharma R&D, business development, regulatory and commercial news. Highlights included our ongoing conference coverage and more analysis of the theoretical biodollar-to-dollar exchange rate. Here are a few of our favorite blog posts and excerpts for stories not covered elsewhere in this month's IN VIVO.
(October 13.) The surprise approval of iloperidone (Fanapt) earned back in May by Vanda Pharmaceuticals Inc. had a lot...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?